Compare Neurocrine Biosciences Inc (NBIX) vs Xcel Energy Inc (XEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Xcel Energy Inc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Xcel Energy Inc trades at $79 (market cap $49.11B). The key difference: Xcel Energy Inc is far larger — about 2.8× Neurocrine Biosciences Inc's market cap, and Xcel Energy Inc pays a 3.01% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | XEL | |
|---|---|---|
Market Cap | $17.40B | $49.11B |
Sector | Health | Utilities |
52-Week High | $180.55 | $83.91 |
52-Week Low | $123.10 | $71.14 |
Enterprise Value | $16.49B | $86.55B |
Dividend Yield | — | 3.01% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Xcel Energy Inc
Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan
Read more on XEL →
